Press release
Mastitis Market 2019 Share Analysis with Pfizer, Novartis AG, Sanofi S.A., AstraZeneca, Genentech Etc. Till 2023
The Global Mastitis Market is expected to reach over 18,338 Million USD by 2023, growing at approximately 15.07% CAGR during the forecast period (2017-2023). In the year 2017, the market had valued at USD 7,898.05 Million.Mastitis Market - Key Players
Some of key the players in the market are Pfizer (U.S.), Novartis AG (Switzerland), Oncogenex (U.S.), Apthera Inc (U.K), BioNumerik Pharmaceuticals (U.S.), Oncothyreon Inc (US), Astellas (Japan), Bipar Sciences (U.S.), Puma Biotechnology (U.S.), Sanofi S.A. (U.S.), Eli Lilly and Company (U.S.), AstraZeneca (UK), F. Hoffmann-La Roche (Switzerland), GlaxoSmithKline (U.K), Genentech (U.S), Teva Pharmaceutical Industries (Israel), Sun Pharmaceutical Industries Ltd (India), Accord Healthcare, Inc. (India), Gilead Sciences, Inc. (U.S.), and others.
Mastitis Market - Segmentation
For the convenience of the report and enhanced understanding; Market is segmented in to 4 key dynamics;
By Types: Comprises Invasive Lobular Carcinoma, Invasive Ductal Carcinoma, and other.
By Treatment: Chemotherapy (Antimetabolites, Anthracyclines, Taxanes & Alkylating Agents), Surgery & Radiation Therapy, Targeted Therapy (Tyrosine Kinase Inhibitors &Monoclonal Antibodies), Biologic Therapy, Hormone Therapy (selective estrogen-receptor modulators (SERMs), aromatase inhibitors) etc.
By End Users: Private Pharmacies and Hospital Pharmacies, etc.
By Regions: APAC, North America, Europe, and Rest of the World.
Segment Chemotherapy holds the largest share as in 45% of the market.
Get Sample Report @ https://www.marketresearchfuture.com/sample_request/5379
Mastitis Market – Insights
Mastitis refers to a kind of infection occurring in the tissues of mammary glands in the breast. The mastitis usually affects women who are breastfeeding as a result of a blocked duct. In cows, mastitis occurs as a result of chemical, mechanical, or thermal injury to the cow's udder.
In addition to the adoption of unhealthy lifestyle other factors driving the market growth include, increasing female geriatric population, exposure to harmful radiation, heredity reasons and genetic mutations (abnormal changes) coupled with the increasing governmental initiatives. Unavailability of absolute treatment presages the large scope for the market to evolve further and prompting to pharmaceutical companies to invest increasingly in R&D to discover novel more effective medicines.
Conversely, high costs pertaining to the treatments, long approval time for the drugs along with the adverse effects associated with therapies are restricting the market growth. Nevertheless, advent Mastitis treatments brought forward during the past few years and the approval of medication called CDK45 Inhibitors, has impacted the market in a big way. CDK45 Inhibitors when used in combination with endocrine therapy for positive Mastitis hormone-receptor, patients have shown improvements in survival – up to 10 months. Additionally, factors such as innovations, e.g. 3-D digital tomosynthesis imaging, Mammography allowing a clearer view through dense breast tissue and changes such as signed bill into law that allows commercial insurance providers to cover breast screening, including 3-D mammography are expected to provide impetus to the market growth.
Mastitis Market - Regional Analysis
The Americas mastitis market is expected to show extensive growth owing to increasing number of patient population for mastitis, and technological advancement in the healthcare. Moreover, high health care spending and increasing government support for research & development are expected to boost the market growth.
Europe holds the second largest share of the global market. The increasing focus of various government agencies on treating mastitis and increasing investment in healthcare domain to improve treatment methods of rare diseases will fuel the growth of the market. The growing public awareness will boost the European market.
The Asia Pacific is the fastest growing mastitis market across the globe. Japan holds the major share of the regional market due to the availability of technology and huge healthcare spending. Rapidly developing the economy, increasing healthcare expenditure, and government initiatives for research & development are projected to drive the market in China and India over the assessment period. Alongside, there is a huge growth outlook for the market in the developing countries as these countries are encouraging research and development in healthcare management.
Browse Complete 90+ Pages Premium Research Report Enabled with 40+ Respective Tables and Figures @ https://www.marketresearchfuture.com/reports/mastitis-market-5379
The Middle East and Africa hold the least share of the global market due to limited availability of medical facilities. The UAE, Saudi Arabia, and Kuwait are expected to drive the Middle East & African market whereas, the African region is expected to witness a moderate growth.
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.
Contact:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune – 411028
Maharashtra, India
+1 646 845 9312
Email: salesteam@marketresearchfuture.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Mastitis Market 2019 Share Analysis with Pfizer, Novartis AG, Sanofi S.A., AstraZeneca, Genentech Etc. Till 2023 here
News-ID: 1619815 • Views: …
More Releases from Market Research Future
Denim Market Size By 2035 with 5.25 USD Billion in 2025 to 132.4 USD Billion, Du …
Denim Market Size Grow at a 75.25 USD Billion in 2025 to 132.4 USD Billion by 2035, CAGR of 5.81% By 2025 - 2035
Global Denim Market is entering a new phase of transformation as consumer demand, fashion cycles, and sustainable innovation continue to reshape the industry. Denim, once considered a classic wardrobe staple, has evolved into a versatile, fashion-driven category supported by innovations in fabric technology, eco-friendly production, and shifting…
Humanoid Robots Market Size to Reach USD 13.8 Billion by 2032, Growing at 50.2% …
The global Humanoid Robots Market is projected to reach USD 13.8 Billion by 2032, growing at a robust CAGR of 50.2% during the forecast period from 2024 to 2032.
Driven by advancements in artificial intelligence, machine learning, and machine vision, humanoid robots-designed with human-like characteristics-are witnessing widespread adoption across healthcare, education, space exploration, and service industries. These robots are enhancing operational efficiency, performing complex tasks, and improving customer engagement across multiple…
Vertical Farming Market Expansion: USD 9.023 Billion in 2025 Growing to USD 58.8 …
The Vertical Farming Market was estimated at USD 7.48 Billion in 2024 and is projected to grow from USD 9.023 Billion in 2025 to USD 58.83 Billion by 2035, exhibiting a robust CAGR of 20.62% during the forecast period from 2025 to 2035.
Driven by increasing demand for sustainable agriculture, urbanization, and technological advancements in controlled-environment farming, vertical farming solutions are seeing widespread adoption across commercial, industrial, and urban agriculture sectors.
Key…
Robotics Market Trends and Forecast: USD 74,120.70 Million in 2024 Expected to H …
The Robotics Market was valued at USD 74,120.70 Million in 2024 and is projected to reach USD 476,019.67 Million by 2035, growing at a robust CAGR of 18.4% during the forecast period from 2024 to 2035.
Driven by advancements in medical robots, growing industrial robotics adoption, and the development of AI technologies, robotics solutions are witnessing widespread adoption across healthcare, manufacturing, logistics, and service sectors. Despite challenges like high initial costs…
More Releases for Mastitis
Mastitis Market Trends & Forecast to 2034
The Mastitis Market is expanding steadily due to rising mastitis prevalence in dairy cattle, increased livestock healthcare spending, and growing adoption of advanced diagnostic and therapeutic solutions. As dairy productivity becomes a global priority, demand for mastitis treatment, prevention products, and rapid diagnostics continues to grow. Below is a full breakdown including key players, segmentation, industry updates, and growth drivers.
Download Full PDF Sample Copy of Market Report
https://exactitudeconsultancy.com/request-sample/51962
1. What Is…
Bovine Mastitis Market Is Booming So Rapidly | Neogen, Vetoquinol, Dechra
The "Bovine Mastitis Market" intelligence report, just published by USD Analytics, covers a micro-level study of important market niches, product offers, and sales channels. To determine market size, potential, growth trends, and competitive environment, the Bovine Mastitis Market provides dynamic views. Both primary and secondary sources of data were used to generate the research, which has both qualitative and quantitative depth. Several of the major figures the study featured Zoetis,…
Bovine Mastitis Market to Witness Stunning Growth | Elanco, Ceva, Virbac
A new business intelligence report released by USD Analytics with title "Global Bovine Mastitis Market Report 2030 " has abilities to raise as the most significant market worldwide as it has remained playing a remarkable role in establishing progressive impacts on the universal economy. The Global Bovine Mastitis Market Report offers energetic visions to conclude and study market size, market hopes, and competitive surroundings. The research is derived through primary…
Bovine Mastitis Market: Current Trends and Future Prospects
The bovine mastitis market was valued at $0.54 billion in 2021 and is estimated to reach $1.01 billion by 2031, growing at a CAGR of 6.3% from 2022 to 2031.
• CAGR: 6.3%
• Current Market Size: USD 0.54 Billion
• Forecast Growing Region: APAC
• Largest Market: North America
• Projection Time: 2021- 2031
• Base Year: 2021
𝐑𝐞𝐪𝐮𝐞𝐬𝐭 𝐑𝐞𝐩𝐨𝐫𝐭 𝐒𝐚𝐦𝐩𝐥𝐞 𝐂𝐨𝐩𝐲 : https://www.alliedmarketresearch.com/request-sample/17988
Bovine mastitis, an inflammatory condition of the mammary gland in dairy cows, poses…
Global Bovine Mastitis Market: Prevalence, Challenges, and Opportunities
The bovine mastitis market was valued at $0.54 billion in 2021 and is estimated to reach $1.01 billion by 2031, growing at a CAGR of 6.3% from 2022 to 2031.
• CAGR: 6.3%
• Current Market Size: USD 0.54 Billion
• Forecast Growing Region: APAC
• Largest Market: North America
• Projection Time: 2021- 2031
• Base Year: 2021
𝐑𝐞𝐪𝐮𝐞𝐬𝐭 𝐑𝐞𝐩𝐨𝐫𝐭 𝐒𝐚𝐦𝐩𝐥𝐞 𝐂𝐨𝐩𝐲 : https://www.alliedmarketresearch.com/request-sample/17988
Bovine mastitis is a prevalent and economically significant disease affecting dairy cattle worldwide.…
Emerging Therapies and Innovations in the Bovine Mastitis Market
Bovine mastitis, a common and costly disease affecting dairy cattle, continues to be a significant challenge for the dairy industry worldwide. It is characterized by inflammation of the udder tissue, leading to reduced milk production, decreased milk quality, and increased treatment costs.
The bovine mastitis market was valued at $0.54 billion in 2021 and is estimated to reach $1.01 billion by 2031, growing at a CAGR of 6.3% from 2022…
